BG107055A - Оралнa система с контролирано освобождаване на ципрофлоксацин за еднократно дневно приемане - Google Patents

Оралнa система с контролирано освобождаване на ципрофлоксацин за еднократно дневно приемане Download PDF

Info

Publication number
BG107055A
BG107055A BG107055A BG10705502A BG107055A BG 107055 A BG107055 A BG 107055A BG 107055 A BG107055 A BG 107055A BG 10705502 A BG10705502 A BG 10705502A BG 107055 A BG107055 A BG 107055A
Authority
BG
Bulgaria
Prior art keywords
formulation
ciprofloxacin
agent
resin
tablet
Prior art date
Application number
BG107055A
Other languages
Bulgarian (bg)
English (en)
Inventor
Naresh Talwar
John Staniforth
Ashok Rampal
Gour Muckherji
Badri VISHWANATHAN
Brij Khera
Original Assignee
Ranbaxy Laboratories Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Limited filed Critical Ranbaxy Laboratories Limited
Publication of BG107055A publication Critical patent/BG107055A/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BG107055A 2000-03-03 2002-09-02 Оралнa система с контролирано освобождаване на ципрофлоксацин за еднократно дневно приемане BG107055A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51788700A 2000-03-03 2000-03-03
PCT/IB2001/000279 WO2001064183A1 (en) 2000-03-03 2001-02-28 Orally administered controlled delivery system for once daily administration of ciprofloxacin

Publications (1)

Publication Number Publication Date
BG107055A true BG107055A (bg) 2003-06-30

Family

ID=24061635

Family Applications (1)

Application Number Title Priority Date Filing Date
BG107055A BG107055A (bg) 2000-03-03 2002-09-02 Оралнa система с контролирано освобождаване на ципрофлоксацин за еднократно дневно приемане

Country Status (31)

Country Link
EP (1) EP1263409A1 (xx)
JP (1) JP2003525229A (xx)
KR (1) KR20030009374A (xx)
CN (1) CN1420763A (xx)
AP (2) AP2001002084A0 (xx)
AR (1) AR032614A1 (xx)
AU (1) AU3589701A (xx)
BG (1) BG107055A (xx)
BR (1) BR0108958A (xx)
CA (1) CA2400950A1 (xx)
CZ (1) CZ20022883A3 (xx)
DO (1) DOP2001000130A (xx)
EA (1) EA200200914A1 (xx)
EC (1) ECSP013952A (xx)
EE (1) EE200200497A (xx)
GT (1) GT200100033A (xx)
HN (1) HN2001000038A (xx)
HR (1) HRP20020715A2 (xx)
HU (1) HUP0204417A3 (xx)
IL (1) IL151553A0 (xx)
IS (1) IS6532A (xx)
MX (1) MXPA02008568A (xx)
NO (1) NO20024108L (xx)
NZ (1) NZ520927A (xx)
OA (1) OA12381A (xx)
PE (1) PE20011113A1 (xx)
PL (1) PL365071A1 (xx)
SK (1) SK12542002A3 (xx)
WO (1) WO2001064183A1 (xx)
YU (1) YU66202A (xx)
ZA (1) ZA200206764B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
US20030229101A1 (en) * 2002-06-06 2003-12-11 Sherman Bernard Charles Tablets comprising ciprofloxacin hydrochloride
DE10351448A1 (de) 2003-11-04 2005-06-09 Bayer Healthcare Ag Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
EP1745775B1 (en) 2005-07-19 2008-05-28 Ethypharm Gastroretentive formulations and manufacturing process thereof.
DE602006012962D1 (de) * 2006-07-19 2010-04-29 Tabuk Pharmaceutical Mfg Co Pharmazeutische Zubereitungen von Ciprofloxacin
EP3247384B1 (en) 2015-01-14 2023-10-04 The Regents of the University of Colorado, a body corporate In vitro method of diagnosis of type 1 diabetes with insulin mimotopes
CA3015400A1 (en) * 2016-02-23 2017-08-31 Matripharm International Inc. Dual-rate release formulation with high drug loading
AU2017236977B2 (en) 2016-03-24 2022-05-26 Immunomolecular Therapeutics, Inc. Methods of treating autoimmune disease
US11052060B2 (en) 2018-02-12 2021-07-06 The Regents Of The University Of Colorado, A Body Corporate Compounds and methods for treating autoimmunity
US11013707B2 (en) 2018-03-23 2021-05-25 The Regents Of The University Of Colorado, A Body Corporate Administration of oral methyldopa
CN109806237A (zh) * 2019-03-13 2019-05-28 悦康药业集团上海制药有限公司 一种乳酸环丙沙星泡腾片及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5096714A (en) * 1988-06-28 1992-03-17 Hauser-Kuhrts, Inc. Prolonged release drug tablet formulations
JPH0624959A (ja) * 1991-10-04 1994-02-01 Bayer Yakuhin Kk 胃内浮遊型薬物徐放性固形製剤
DE4406424A1 (de) * 1994-02-28 1995-08-31 Bayer Ag Expandierbare Arzneiformen
DE19839057A1 (de) * 1998-08-28 2000-03-02 Koch Berthold Spülluft-Regler für eine Trockenvorrichtung für Druckluft
NZ510487A (en) * 1998-09-14 2003-04-29 Ranbaxy Lab Ltd Pharmaceutical composition comprising ciprofloxacin, sodium alginate, xanthan gum and a cross-linker polymer in a tablet or capsule form

Also Published As

Publication number Publication date
EP1263409A1 (en) 2002-12-11
HUP0204417A3 (en) 2005-03-29
DOP2001000130A (es) 2004-03-31
KR20030009374A (ko) 2003-01-29
YU66202A (sh) 2005-09-19
EA200200914A1 (ru) 2003-02-27
AP2002002627A0 (en) 2002-09-30
GT200100033A (es) 2001-10-25
HUP0204417A2 (en) 2003-05-28
AR032614A1 (es) 2003-11-19
CZ20022883A3 (cs) 2003-04-16
NZ520927A (en) 2003-06-30
IS6532A (is) 2002-08-28
CN1420763A (zh) 2003-05-28
JP2003525229A (ja) 2003-08-26
ECSP013952A (es) 2002-04-23
PL365071A1 (en) 2004-12-27
NO20024108D0 (no) 2002-08-28
EE200200497A (et) 2004-02-16
CA2400950A1 (en) 2001-09-07
WO2001064183A1 (en) 2001-09-07
NO20024108L (no) 2002-10-25
AU3589701A (en) 2001-09-12
HRP20020715A2 (en) 2004-12-31
PE20011113A1 (es) 2001-10-14
ZA200206764B (en) 2003-03-04
IL151553A0 (en) 2003-04-10
HN2001000038A (es) 2005-03-23
SK12542002A3 (sk) 2003-05-02
BR0108958A (pt) 2003-09-30
AP1485A (en) 2005-10-31
AP2001002084A0 (en) 2001-03-31
MXPA02008568A (es) 2003-02-24
OA12381A (en) 2004-09-06

Similar Documents

Publication Publication Date Title
US6261601B1 (en) Orally administered controlled drug delivery system providing temporal and spatial control
AU758324B2 (en) Orally administered controlled drug delivery system providing temporal and spatial control
US5811126A (en) Controlled release matrix for pharmaceuticals
US6899896B2 (en) Hydrogel-driven layered drug dosage form
JP2013519726A (ja) バクロフェン療法に感受性の病状の治療方法
BG107055A (bg) Оралнa система с контролирано освобождаване на ципрофлоксацин за еднократно дневно приемане
EP4313014A1 (en) A method for the production of gastroretentive compact matrices for the controlled release of active substances and compact matrices thus obtained
US20230390192A1 (en) Gastro retentive dosage forms comprising deutetrabenazine
AU2006201553A1 (en) Orally administered controlled delivery system for once daily administration of ciprofloxacin
CN112137978A (zh) 一种胃保留改性释放的固体药物组合物、制备方法及应用
WO2008102235A1 (en) Controlled release formulations of alfuzosin